Moneta Group Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Sell
30,548
-6
-0% -$350 0.01% 276
2025
Q4
$1.65M Sell
30,554
-5,899
-16% -$284K 0.01% 288
2025
Q3
$1.64M Sell
36,453
-6,916
-16% -$323K 0.01% 282
2025
Q2
$2.01M Sell
43,369
-1,867
-4% -$91.6K 0.02% 223
2025
Q1
$2.76M Buy
45,236
+2,487
+6% +$145K 0.04% 173
2024
Q4
$2.42M Buy
42,749
+4,435
+12% +$248K 0.03% 186
2024
Q3
$1.98M Buy
38,314
+1,193
+3% +$56K 0.03% 199
2024
Q2
$1.54M Buy
37,121
+6,075
+20% +$272K 0.02% 216
2024
Q1
$1.68M Buy
31,046
+13,011
+72% +$663K 0.03% 205
2023
Q4
$925K Sell
18,035
-2,663
-13% -$140K 0.02% 250
2023
Q3
$1.2M Sell
20,698
-4,159
-17% -$255K 0.03% 200
2023
Q2
$1.59M Buy
24,857
+680
+3% +$45.6K 0.04% 189
2023
Q1
$1.68M Buy
24,177
+8,506
+54% +$600K 0.04% 179
2022
Q4
$1.14M Sell
15,671
-3,108
-17% -$234K 0.03% 192
2022
Q3
$1.33M Sell
18,779
-377
-2% -$27.3K 0.05% 166
2022
Q2
$1.48M Buy
19,156
+2,218
+13% +$169K 0.05% 172
2022
Q1
$1.24M Sell
16,938
-63
-0.4% -$4.23K 0.05% 177
2021
Q4
$1.06M Sell
17,001
-2,181
-11% -$128K 0.04% 194
2021
Q3
$1.14M Sell
19,182
-1,291
-6% -$85K 0.05% 179
2021
Q2
$1.37M Buy
20,473
+1,655
+9% +$108K 0.06% 166
2021
Q1
$1.19M Buy
18,818
+9,435
+101% +$587K 0.06% 159
2020
Q4
$582K Buy
9,383
+1,289
+16% +$79.3K 0.04% 183
2020
Q3
$488K Sell
8,094
-3,079
-28% -$185K 0.04% 169
2020
Q2
$657K Buy
11,173
+7,118
+176% +$426K 0.06% 134
2020
Q1
$226K Sell
4,055
-1,865
-32% -$114K 0.02% 212
2019
Q4
$380K Sell
5,920
-2,264
-28% -$130K 0.03% 190
2019
Q3
$415K Buy
8,184
+400
+5% +$18.8K 0.04% 179
2019
Q2
$353K Sell
7,784
-2,696
-26% -$126K 0.03% 182
2019
Q1
$500K Buy
10,480
+1,419
+16% +$70.7K 0.05% 141
2018
Q4
$471K Buy
9,061
+499
+6% +$26.8K 0.06% 142
2018
Q3
$532K Sell
8,562
-10,370
-55% -$615K 0.05% 145
2018
Q2
$1.05M Buy
18,932
+9,230
+95% +$498K 0.12% 105
2018
Q1
$614K Buy
9,702
+5,093
+111% +$328K 0.08% 109
2017
Q4
$282K Buy
4,609
+481
+12% +$30.1K 0.04% 159
2017
Q3
$263K Sell
4,128
-2,581
-38% -$151K 0.04% 169
2017
Q2
$374K Buy
+6,709
New +$365K 0.06% 144
2017
Q1
Sell
-7,128
Closed -$417K 161
2016
Q4
$417K Sell
7,128
-316
-4% -$17.3K 0.09% 104
2016
Q3
$401K Sell
7,444
-2,590
-26% -$166K 0.09% 91
2016
Q2
$738K Buy
10,034
+900
+10% +$63.6K 0.16% 88
2016
Q1
$583K Buy
9,134
+2,538
+38% +$160K 0.13% 94
2015
Q4
$454K Sell
6,596
-214
-3% -$14.1K 0.11% 86
2015
Q3
$403K Sell
6,810
-976
-13% -$61.9K 0.11% 85
2015
Q2
$518K Sell
7,786
-5,341
-41% -$352K 0.16% 72
2015
Q1
$847K Sell
13,127
-215
-2% -$13.5K 0.36% 46
2014
Q4
$788K Sell
13,342
-1,766
-12% -$99.6K 0.38% 44
2014
Q3
$773K Buy
15,108
+482
+3% +$24.1K 0.4% 41
2014
Q2
$710K Buy
14,626
+100
+0.7% +$4.93K 0.38% 45
2014
Q1
$755K Sell
14,526
-380
-3% -$20.2K 0.45% 35
2013
Q4
$792K Sell
14,906
-270
-2% -$13.8K 0.48% 36
2013
Q3
$702K Buy
15,176
+510
+3% +$22.4K 0.46% 41
2013
Q2
$655K Buy
+14,666
New +$637K 0.46% 41

Other funds holding BMY

Moneta Group Investment Advisors's BMY Position: Q1 2026 in Review

Moneta Group Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.02% in Q1 2026, selling an estimated $350 and leaving 30,548 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #276.

Moneta Group Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.76M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Moneta Group Investment Advisors held 30,548 shares of Bristol-Myers Squibb worth $1.85M as of Q1 2026.
  • Moneta Group Investment Advisors sold 6 Bristol-Myers Squibb shares in Q1 2026, an estimated $350.
  • Bristol-Myers Squibb made up 0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #276 holding.
  • Moneta Group Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Moneta Group Investment Advisors's Bristol-Myers Squibb position peaked at $2.76M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.